NO20010593L - Preparat og fremgangsmÕte for behandling av Peyronies sykdom og andre subdermale plakkmanifestasjonsforstyrrelser - Google Patents

Preparat og fremgangsmÕte for behandling av Peyronies sykdom og andre subdermale plakkmanifestasjonsforstyrrelser

Info

Publication number
NO20010593L
NO20010593L NO20010593A NO20010593A NO20010593L NO 20010593 L NO20010593 L NO 20010593L NO 20010593 A NO20010593 A NO 20010593A NO 20010593 A NO20010593 A NO 20010593A NO 20010593 L NO20010593 L NO 20010593L
Authority
NO
Norway
Prior art keywords
peyronie
subdermal
manifestation
plaque
disorders
Prior art date
Application number
NO20010593A
Other languages
English (en)
Other versions
NO20010593D0 (no
Inventor
W Jerry Easterling
Original Assignee
W Jerry Easterling
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22433651&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20010593(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by W Jerry Easterling filed Critical W Jerry Easterling
Publication of NO20010593D0 publication Critical patent/NO20010593D0/no
Publication of NO20010593L publication Critical patent/NO20010593L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20010593A 1998-08-03 2001-02-05 Preparat og fremgangsmÕte for behandling av Peyronies sykdom og andre subdermale plakkmanifestasjonsforstyrrelser NO20010593L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/128,103 US6031005A (en) 1998-08-03 1998-08-03 Composition and method for treating Peyronie's disease and related connective tissue disorders
PCT/US1999/016082 WO2000007587A1 (en) 1998-08-03 1999-07-16 Composition and method for treating peyronie's disease and other sub-dermal plaque manifestation disorders

Publications (2)

Publication Number Publication Date
NO20010593D0 NO20010593D0 (no) 2001-02-05
NO20010593L true NO20010593L (no) 2001-04-02

Family

ID=22433651

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010593A NO20010593L (no) 1998-08-03 2001-02-05 Preparat og fremgangsmÕte for behandling av Peyronies sykdom og andre subdermale plakkmanifestasjonsforstyrrelser

Country Status (6)

Country Link
US (2) US6031005A (no)
EP (1) EP1105113A4 (no)
AU (1) AU765215B2 (no)
CA (1) CA2339003A1 (no)
NO (1) NO20010593L (no)
WO (1) WO2000007587A1 (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU753270B2 (en) * 1998-05-21 2002-10-10 Isis Pharmaceuticals, Inc. Compositions and methods for topical delivery of oligonucleotides
US20020151537A1 (en) * 1998-08-03 2002-10-17 Easterling W. Jerry Composition and method for treating erectile dysfunction and reducing fibrosis in erectile tissue of the human penis
US20020022664A1 (en) * 1998-08-03 2002-02-21 Easterling W. Jerry Method for treating aberrant fibrotic tissue manifestations with topical calcium channel blocker preparations and improved composition for such treatment and improved method for the manufacture thereof
US20020160995A1 (en) * 1998-08-03 2002-10-31 Easterling W. Jerry Medication and method for remediating existing scars through transdermal, topical delivery of calcium channel blockers
US20040170675A1 (en) * 1998-08-03 2004-09-02 Easterling W. Jerry Noninvasive method for treating cellulite through transdermal delivery of calcium channel blocker agents and medicament for use in such method
US20020019445A1 (en) * 1998-08-03 2002-02-14 Easterling W. Jerry Noninvasive method for treating cellulite through transdermal delivery of calcium channel blocker agents and medicament for use in such method
US6627663B2 (en) * 1998-08-03 2003-09-30 W. Jerry Easterling Noninvasive method for treating hemangiomas through transdermal delivery of calcium channel blocker agents and medicament for use in such method
BR0006719A (pt) * 2000-05-04 2001-09-25 Cristiano Alberto Ribeiro Sant Composição em forma de creme, gel e creme gel aplicada na terapêutica da doença de peyronie, de colagenoses e patologias fibróticas à base de vitamina-e, papaìna 2% e hialuronidase
US20050176782A1 (en) * 2002-02-26 2005-08-11 Easterling W. J. Medicament and method for treating vulodynia
US20030162769A1 (en) * 2002-02-26 2003-08-28 Easterling W. Jerry Composition and method for treating vulvodynia
ES2197018B1 (es) * 2002-06-06 2005-10-01 Especialidades Farmaceuticas Centrum Sa Nuevo uso terapeutico de los extractos de polypodium.
US20040147534A1 (en) * 2003-01-23 2004-07-29 Foote Mary Ann Topical composition and method for treating occlusive wounds
JP2007519756A (ja) * 2004-01-30 2007-07-19 アンジオテック インターナショナル アーゲー 拘縮を治療するための組成物および方法
US20060216338A1 (en) * 2005-02-07 2006-09-28 Easterling W J Composition and method of treatment for heel pain
US7851431B2 (en) * 2005-07-27 2010-12-14 Prescription Dispensing Laboratories Treatment of actinic keratoses with calcium channel blockers
US8323642B2 (en) * 2006-12-13 2012-12-04 Depuy Mitek, Inc. Tissue fusion method using collagenase for repair of soft tissue
TWI395593B (zh) 2008-03-06 2013-05-11 Halozyme Inc 可活化的基質降解酵素之活體內暫時性控制
US20100061972A1 (en) * 2008-08-19 2010-03-11 Auxilium US Holdings,LLC Method of Treating Peyronie's Disease
JP5649589B2 (ja) * 2009-03-06 2015-01-07 ハロザイム インコーポレイテッド マトリックスメタロプロテアーゼ１の温度感受性突然変異体およびその使用
US20110306820A1 (en) * 2010-06-14 2011-12-15 Coloplast A/S Method of treating incontinence
EP2632446B1 (en) 2010-10-30 2018-12-12 Oxford University Innovation Limited Treatment for dupuytren's disease
US8465413B2 (en) 2010-11-25 2013-06-18 Coloplast A/S Method of treating Peyronie's disease
JP6049714B2 (ja) 2011-07-20 2016-12-21 メディウンド リミテッド 結合組織疾患の治療のためのブロメライン由来タンパク質分解抽出物
GB201119089D0 (en) * 2011-11-04 2011-12-21 Isis Innovation Treatment of musculoskeletal fibroproliferative disorders
EP2804606B1 (en) 2012-01-19 2017-06-28 Hybrid Medical, LLC Topical therapeutic formulations
US10471131B2 (en) 2012-01-19 2019-11-12 Hybrid Medical, Llc Topical therapeutic formulations
WO2014107745A1 (en) 2013-01-07 2014-07-10 Halozyme, Inc. Metal sensitive mutants of matrix metalloproteases and uses thereof
US20180360751A1 (en) * 2017-06-19 2018-12-20 Advanced Fibrosis Research LLC Transdermal cream for treating Dupuytren's Contracture
CN112294767A (zh) * 2020-11-17 2021-02-02 海南锦瑞制药有限公司 一种注射用盐酸地尔硫卓冻干粉针剂及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338300A (en) * 1981-02-05 1982-07-06 The Regents Of The University Of California Use of purified clostridial collangenase in the treatment of Peyronie's disease
US4557934A (en) * 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
US5139944A (en) * 1985-08-10 1992-08-18 Biophram (Uk) Limited Collagen-specific enzyme with platelet aggregation inhibition properties
US5569678A (en) 1989-07-31 1996-10-29 Massachusetts Institute Of Technology Control of wound scar production
EP0485470B1 (en) * 1989-07-31 1994-03-16 Massachusetts Institute Of Technology Use of calcium antagonists for treating scars
ZA906583B (en) * 1989-08-21 1991-09-25 Beth Israel Hospital Method and composition for the treatment of cutaneous,ocular,and mucosal hypersensitivity,inflammatory,and hyperproliferative conditions using topical preparations of nifedipine
SE463443B (sv) * 1989-10-11 1990-11-26 Pelly Ind Ab Hopfaellbar strykbraeda
US5242391A (en) * 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
DE69334068D1 (de) * 1992-07-20 2006-11-16 Massachusetts Inst Technology Kontrolle der wundvernarbung mit calmodulin-inhibitoren oder protein-kinase-c-inhibitoren
US5552162A (en) * 1993-02-09 1996-09-03 Arch Development Corporation Method for improvement of scar size and appearance
WO1994023748A1 (en) * 1993-04-08 1994-10-27 The University Of Queensland Administration of vaso-active agent and therapeutic agent
AU704222B2 (en) * 1995-03-24 1999-04-15 Genzyme Corporation Reduction of adhesions using controlled delivery of active oxygen inhibitors
US5731339A (en) * 1995-04-28 1998-03-24 Zonagen, Inc. Methods and formulations for modulating the human sexual response

Also Published As

Publication number Publication date
US20010047037A1 (en) 2001-11-29
US6353028B2 (en) 2002-03-05
NO20010593D0 (no) 2001-02-05
WO2000007587A1 (en) 2000-02-17
AU765215B2 (en) 2003-09-11
CA2339003A1 (en) 2000-02-17
EP1105113A4 (en) 2002-08-21
EP1105113A1 (en) 2001-06-13
WO2000007587A9 (en) 2000-08-03
US6031005A (en) 2000-02-29
AU5105599A (en) 2000-02-28

Similar Documents

Publication Publication Date Title
NO20010593D0 (no) Preparat og fremgangsmåte for behandling av Peyronie's sykdom og andre subdermale plakkmanifestasjonsforstyrrelser
CY2018020I2 (el) Θεραπεια της νοσου ρομρε
CY2020003I1 (el) Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις για την θεραπευτικη αγωγη της παθολογιας του crohn
NO951761D0 (no) Stabilt preparat for behandling av blodkoagulasjonssykdommer
NO963568D0 (no) Farmasöytisk preparat for behandling av blodkoagulasjonssykdommer, fremgangsmåter for fremstilling av dette og dets anvendelse
AU2001249835A1 (en) Diagnosis and treatment of alzheimer's disease
NO972972L (no) Sammensetninger for behandling av dermatologiske forstyrrelser og metoder for deres anvendelse
NO20004098L (no) FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser
NO992755D0 (no) Protese for °yets senehinne for behandling av presbyopi og andre forstyrrelser i °yner
NO20022531D0 (no) Vaksine for forebyggelse og behandling av Alzheimer og amyloidrelaterte sykdommer
NO994613D0 (no) Fremgangsmaate og preparat til behandling av sövn-apne
DE69630479D1 (de) Arzneimittel zur Behandlung von entzündlichen Herzkrankheiten
HUP0003852A3 (en) Use of highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
NO20002686D0 (no) Forbedring av Peyronies sykdom
NO20015969D0 (no) Forbedret sklerittprotese for behandling av presbyopi og andre öyesykdommer
NO20001869D0 (no) Fremgangsmõte for behandling av Alzheimerssykdom
AU2002239765A1 (en) Antibody pti-hs7 for treatment of alzheimer's disease and other amyloidoses and parkinson's disease
AU3886200A (en) Methods of treating alzheimer's disease and other amyloidoses using hypericum perforatum and derivatives thereof
AU3364499A (en) Method for delaying the onset of alzheimer's disease and for treating or delaying the onset of other amyloidosis-related diseases/disorders
AU2002222108A1 (en) Diagnosis and treatment of alzheimer's disease
NO302334B1 (no) Terapeutisk smertestillende middel inneholdende "Nimesulid", samt fremgangsmåte ved fremstilling derav
NO963130D0 (no) Preparat for behandling av glaukom, omfattende pilokarpin og en betablokker
FI982689L (fi) 2-fenyyli-1,2-bentsoisoselenatsol-3(2H)-onin käyttö Alzheimerin taudin käsittelyyn tarkoiettujen farmaseuttisten valmisteiden valmistukseen
AU5550800A (en) Diagnosis and treatment of alzheimer's disease
DE69739190D1 (de) Arzneimittel zur behandlung von oculären kreislauferkrankungen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application